The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?-Reference-Cited by-同舟云学术

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?

Published:2018-07-18 Issue:5 Volume:18 Page:475-486
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Sandmann Frank G.¹,Mostardt Sarah²,Lhachimi Stefan K.³⁴,Gerber-Grote Andreas⁵

Affiliation:

1. Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK

2. Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany

3. Research Group Evidence-Based Public Health, Leibniz-Institute for Epidemiology and Prevention Research (BIPS), Bremen, Germany

4. Institute for Public Health and Nursing, Health Sciences Bremen, University Bremen, Bremen, Germany

5. School of Health Professions, Zurich University of Applied Sciences, Winterthur, Switzerland

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1497976

Reference77 articles.

1. Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures?

2. The German health care system at the crossroads

3. Systematic overview of cost–effectiveness thresholds in ten countries across four continents

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10 Jahre AMNOG: ‚Value-based Pricing‘ mit einem Monopsonisten und seine Implikationen für die gesetzlich intendierte Zielsetzung;Sozialer Fortschritt;2024-05-01

2. Institutional design and moral conflict in health care priority-setting;Medicine, Health Care and Philosophy;2024-04-04

3. Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis;JAMA Dermatology;2024-04-01

4. Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer;Value in Health Regional Issues;2023-09

5. Grundkonzepte und Einsatz von Kosten-Nutzen-Bewertungen im internationalen Überblick;Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen;2022-11